ArticleStroke and vascular neurology2024

Rationale and design of ProUrokinase in Mild IsChemic strokE (PUMICE): a multicentre, prospective, randomised, open-label, blinded-endpoint controlled trial.

Yunyun Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.